|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0185 | ED148387 | General Research Use | No | Female | White | 62 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_0506 | ED149124 | General Research Use | No | Male | White | 74 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0899 | ED148845 | General Research Use | No | Male | White | 75 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1032 | ED148211 | Eye Disease Only | No | Female | White | 76 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1501 | ED148394 | General Research Use | No | Female | White | 66 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 10 - Central GA |
| AR2_3161 | ED148166 | General Research Use | No | Female | White | 74 | 7 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_3269 | ED149318 | General Research Use | No | Female | White | 80 | 8 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_3577 | ED149426 | General Research Use | No | Female | White | 72 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0049 | ED148151 | General Research Use | No | Male | White | 79 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1649 | ED149054 | General Research Use | No | Female | White | 79 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_1776 | ED149637 | General Research Use | No | Female | White | 63 | 10 - Central GA | 10 - Central GA |
| AR2_2001 | ED148120 | General Research Use | No | Female | White | 81 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2899 | ED149069 | General Research Use | No | Female | White | 66 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_3031 | ED148733 | General Research Use | No | Male | White | 61 | 10 - Central GA | 10 - Central GA |
| AR2_3172 | ED149628 | General Research Use | No | Female | White | 51 | 10 - Central GA | 10 - Central GA |
| AR2_3312 | ED148441 | General Research Use | No | Male | White | 72 | 10 - Central GA | 10 - Central GA |
| AR2_3857 | ED149964 | General Research Use | No | Male | White | 70 | 8 - AREDS AMD Severity Scale Step 5 | 10 - Central GA |
| AR2_4044 | ED149327 | General Research Use | No | Female | White | 61 | 7 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_4065 | ED149067 | General Research Use | No | Female | White | 77 | 10 - Central GA | 10 - Central GA |
| AR2_0884 | ED148543 | General Research Use | No | Male | White | 76 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 10 - Central GA |